UPDATED May 14, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$2.62 | 3.6% | 60.7% | US$631.4m | US$3.63 | PS1x | E158.5% | n/a | ||
ASRT | US$1.01 | -9.0% | -85.2% | US$99.9m | US$3.00 | PB0.7x | E155.2% | n/a | ||
PHIO | US$0.73 | -12.3% | -82.1% | US$3.2m | US$4.00 | PB0.6x | E152.5% | n/a | ||
SBFM | US$0.90 | -11.8% | -98.4% | US$866.3k | US$15.00 | PB0.04x | E144.2% | n/a | ||
NBY | US$0.084 | -2.9% | -88.3% | US$2.9m | US$2.60 | PE-0.2x | E139.7% | n/a | ||
LFCR | US$6.12 | -10.9% | 35.4% | US$186.6m | US$6.00 | PS1.8x | E138.1% | n/a | ||
VCYT | US$23.02 | 9.5% | -6.3% | US$1.7b | US$29.83 | PS4.7x | E123.7% | n/a | ||
AMRX | US$6.85 | 5.2% | 237.4% | US$2.1b | US$8.25 | PE-12.5x | E118.9% | 0% | ||
ETON | US$3.63 | -2.4% | 0.8% | US$91.2m | US$8.00 | PE102.1x | E117.7% | n/a | ||
PLX | US$1.16 | 1.8% | -46.5% | US$83.6m | US$13.00 | PE12.4x | E117.4% | n/a | ||
MRVI | US$10.70 | 19.4% | -20.1% | US$2.7b | US$10.42 | PS5.2x | E111.0% | n/a | ||
CKPT | US$1.56 | -7.7% | -44.1% | US$55.0m | US$17.25 | PS818.7x | E109.1% | n/a | ||
MLAB | US$118.11 | 2.5% | -24.6% | US$627.7m | US$130.00 | PE672x | E108.3% | 0.5% | ||
YCBD | US$0.71 | -11.6% | -65.0% | US$2.1m | US$2.00 | PB0.3x | E107.1% | n/a | ||
HBIO | US$3.43 | -8.5% | -36.8% | US$147.2m | US$7.00 | PS1.4x | E106.7% | n/a | ||
EVOK | US$0.47 | 0% | -75.0% | US$4.0m | US$7.00 | PE-0.5x | E101.6% | n/a | ||
PRPH | US$5.07 | 0.2% | -42.0% | US$95.5m | US$18.50 | PS3.2x | E97.4% | 0% | ||
CDXC | US$3.66 | -2.4% | 144.0% | US$255.2m | US$6.34 | PS3.3x | E96.7% | n/a | ||
AYTU | US$3.32 | 8.5% | 88.6% | US$18.7m | US$8.00 | PB0.6x | E96.6% | n/a | ||
ALVO | US$13.35 | -3.7% | 42.2% | US$3.7b | US$16.50 | PS40x | E95.2% | n/a | ||
BHC | US$7.12 | -3.9% | 18.3% | US$2.6b | US$9.79 | PE-5.7x | E95.1% | n/a | ||
CTKB | US$6.30 | -1.3% | -8.6% | US$811.3m | US$9.80 | PS4.1x | E93.2% | n/a | ||
CTLT | US$55.52 | -1.8% | 74.3% | US$10.1b | US$63.50 | PS2.4x | E91.8% | n/a | ||
ELAN | US$17.07 | 26.3% | 99.9% | US$8.4b | US$19.11 | PS1.9x | E91.6% | n/a |